Shares of Progyny PGNY were flat in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were up 66.67% over the past year to $0.05, which were in line with the estimate of $0.05.
Revenue of $98,928,000 rose by 61.66% from the same period last year, which beat the estimate of $92,590,000.
Looking Ahead
Progyny hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Nov 05, 2020
Time: 04:45 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/fm7d7u3t
Price Action
Company's 52-week high was at $36.50
52-week low: $15.59
Price action over last quarter: Up 6.45%
Company Description
Progyny Inc is a United States based company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.